Double blind comparative randomized study to evaluate efficacy and safety of CP-010, Homeopathy drug as compare to Magnesium Phosphoricum in the management of sub-acute and chronic painful conditions.â?? - Nil

Homeopathy India Private Limited0 个研究点目标入组 116 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with moderate to severe pain at baseline (NRS 4 - 10) (Indicating the intensity of pain.),Any Sub-acute and chronic painful condition.Patients who continue to have significant pain in spite of any form of pain killer medication. Such patients should be able to manage without increasing the dose of current pain-killers or changing to another pain-killer medicine, during the course of study. Patient has been informed about the study and has given her/his written informed consent.Patient understands the investigational nature of the extension study and is willing and willing to comply with trial protocol. Patients having any sub-acute or chronic pain.

•Patients with severe pain due to critical conditions such as chronic abdominal conditions such as appendicitis, cholicytisis, pancreatitis, renal colic, acute rheumatoid arthritis, severe psoriatic arthritis, septic arthritis, etc.Pregnant and lactating women,Mentally retarded patients,Patients with severe or incapacitating baseline pain.Participation in a clinical trial with an investigational agent during the past 30 days or Simultaneous participation in a clinical study, Severe uncontrolled systemic disease such as diabetes, hypertension.

发起方

Homeopathy India Private Limited